找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Russia’s Domestic Security Wars; Putin’s Use of Divid Peter Reddaway Book 2018 The Editor(s) (if applicable) and The Author(s) 2018 Russia.

[復(fù)制鏈接]
樓主: Clinton
31#
發(fā)表于 2025-3-26 23:13:25 | 只看該作者
32#
發(fā)表于 2025-3-27 01:30:09 | 只看該作者
Peter Reddawayly a small proportion of the population. Although tumor size, histologic grade, and steroid receptor status provide information suggesting recurrence risk for large groups of patients, there remains no satisfactory tool for accurate prediction of recurrence in the individual.
33#
發(fā)表于 2025-3-27 05:25:45 | 只看該作者
34#
發(fā)表于 2025-3-27 11:55:14 | 只看該作者
35#
發(fā)表于 2025-3-27 15:28:35 | 只看該作者
Peter Reddawayt at diagnosis of risk criteria sensitive enough to reliably distinguish the low- and high-risk categories, the second volume, by provid- ing a review of the main problems and results of therapy given to high-risk patients, can be considered as a continua- tion of the first book. A refined risk assessment at 978-3-642-74730-4978-3-642-74728-1
36#
發(fā)表于 2025-3-27 20:42:21 | 只看該作者
Peter Reddaway as discussed by Neidhart (this volume), over the more conventionally used regimen of using a combination of cyclophosphamide, methotrexate, and fluorouracil (CMF) is emerging as a result of several recent studies. The whole issue of dose intensity, discussed in more detail by Hryniuk et al. (this v
37#
發(fā)表于 2025-3-28 00:00:46 | 只看該作者
Peter Reddaway as discussed by Neidhart (this volume), over the more conventionally used regimen of using a combination of cyclophosphamide, methotrexate, and fluorouracil (CMF) is emerging as a result of several recent studies. The whole issue of dose intensity, discussed in more detail by Hryniuk et al. (this v
38#
發(fā)表于 2025-3-28 04:28:12 | 只看該作者
39#
發(fā)表于 2025-3-28 07:49:34 | 只看該作者
Peter Reddawayosis of risk criteria sensitive enough to reliably distinguish the low- and high-risk categories, the second volume, by provid- ing a review of the main problems and results of therapy given to high-risk patients, can be considered as a continua- tion of the first book. A refined risk assessment at
40#
發(fā)表于 2025-3-28 13:57:11 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-22 17:58
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
平凉市| 通许县| 郁南县| 临安市| 嵊泗县| 莒南县| 凤城市| 石楼县| 蓝山县| 福州市| 都昌县| 清原| 保山市| 柞水县| 罗城| 韶关市| 嘉善县| 张掖市| 永嘉县| 阳山县| 平凉市| 桂林市| 灵川县| 吉木乃县| 朝阳区| 新泰市| 乐清市| 绿春县| 金沙县| 蕉岭县| 盱眙县| 集安市| 常德市| 都江堰市| 喀喇沁旗| 潜山县| 安福县| 东兰县| 中西区| 西华县| 陆川县|